Technology
AtriCure Inc. launched the cryoFORM cryoablation probe, which offers increased probe flexibility to adapt to a variety of surgical ablation procedures. This offering adds to the cryoICE family of ablation products which are used in the cryosurgical treatment of cardiac arrhythmias.
October 02, 2015
Technology | Antiplatelet and Anticoagulation Therapies
AstraZeneca announced that Brilinta (ticagrelor) 60-mg tablets are now available in U.S. pharmacies. On Sept. 3, 2015, the U.S. Food and Drug Administration (FDA) approved a new 60-mg dosage strength for Brilinta to be used in patients with a history of heart attack beyond the first year.
October 02, 2015
Intact Vascular Inc. announced the U.S. Food and Drug Administration has granted conditional approval for a U.S. and European investigational device exemption (IDE) clinical trial of the Tack Endovascular System.
October 01, 2015Sponsored Content
Feature
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 17, 2025
News | Stents Peripheral
Kimihiko Kichikawa, M.D., department of radiology at Nara Medical University in Japan, reported two-year results of the Zilver PTX post-market surveillance (PMS) study at the 2015 Cardiovascular and Interventional Radiology Society of Europe (CIRSE) meeting in Lisbon, Portugal. Kichikawa’s presentation focused on initial target data on lesion revascularization (TLR).
October 01, 2015
News | Stents Peripheral
Stentys announced that the company’s drug-eluting stent received CE Mark for treatment of below-the-knee (BTK) arteries. The approval makes it the first self-expanding and drug-eluting stent with regulatory approval in Europe for this indication.
October 01, 2015
Technology | Contrast Media Injectors
Galt Medical has partnered with Health Line International Corp. and launched the Nexus CT Midline Catheter with MST Insertion Kit.
October 01, 2015Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
News | Enterprise Imaging
October 1, 2015 — Infinitt North America will feature the Infinitt Healthcare Platform (IHP) at RSNA 2015. This ...
October 01, 2015
News | Radiation Dose Management
October 1, 2015 — The first and only system that delivers real-time X-ray radiation dose monitoring for physicians and ...
October 01, 2015
News | Stem Cell Therapies
A sticky, protein-rich gel created by Johns Hopkins researchers appears to help stem cells stay on or in rat hearts and restore their metabolism after transplantation, improving cardiac function after simulated heart attacks, according to results of a new study.
September 29, 2015Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
News | Heart Failure
September 29, 2015 — A new report from the American Heart Association (AHA) projects that the number of Americans ...
September 29, 2015News | Cath Lab
The Innovation Institute announced that Boston Scientific has signed an agreement to become the founding medical device sponsor of the institute’s Innovation Lab in Newport Beach, California.
September 29, 2015
News | Stents Peripheral
New 12-month clinical trial outcomes assessing the safety and performance of the Boston Scientific Eluvia drug-eluting vascular stent system reflect a primary patency rate of more than 96 percent.
September 28, 2015Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News | EP Lab
Researchers have discovered how to predict some cardiac arrhythmias several steps before they even occur. It’s a finding that could lead to an improved cardiac device, with equipment designed to detect when arrhythmias are about to occur and then act to prevent them.
September 28, 2015The Icahn School of Medicine at Mount Sinai has launched the international TWILIGHT clinical trial to test the safety and effectiveness of treating coronary stent patients with ticagrelor alone instead of combining it with aspirin, which is the current standard of care.
September 25, 2015
News | Hypertension
Medisafe, an mHealth platform for medication management, announced the results of its blood pressure study, which showed app users with stage 1 or stage 2 hypertension decreased their systolic blood pressure by 17.7 and 25.3 mmHg, respectively, within 30 days.
September 25, 2015